Performance of TXG 10X Genomics | -53.5% in 12m
Compare TXG with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare 10X Genomics with its related Sector/Index XLV
Performance Duell TXG vs XLV
| TimeFrame | TXG | XLV |
|---|---|---|
| 1 Day | -2.98% | -0.34% |
| 1 Week | -5.79% | 1.07% |
| 1 Month | -30.5% | -0.48% |
| 3 Months | -47.7% | -1.06% |
| 6 Months | -33.1% | 11.75% |
| 12 Months | -53.5% | 8.34% |
| YTD | -53.3% | 2.75% |
| Rel. Perf. 1m | -3.39 | |
| Rel. Perf. 3m | -8.25 | |
| Rel. Perf. 6m | -5.00 | |
| Rel. Perf. 12m | -8.10 |
Is 10X Genomics a good stock to buy?
No, based on ValueRay Fundamental Analyses, 10X Genomics (NASDAQ:TXG) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -56.77 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TXG as of May 2024 is 20.35. This means that TXG is currently overvalued and has a potential downside of -19.76% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TXG as of May 2024 is 20.35. This means that TXG is currently overvalued and has a potential downside of -19.76% (Sold with Premium).
Is TXG a buy, sell or hold?
- Strong Buy: 8
- Buy: 4
- Hold: 3
- Sell: 1
- Strong Sell: 0
Values above 0%: TXG is performing better - Values below 0%: TXG is underperforming
Compare TXG with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -9.16% | -30.23% | -52.27% | -80.57% |
| US NASDAQ 100 | QQQ | -10.19% | -30.40% | -51.59% | -90.31% |
| US Dow Jones Industrial 30 | DIA | -8.85% | -30.93% | -48.68% | -71.84% |
| German DAX 40 | DBXD | -9.08% | -31.29% | -54.22% | -68.86% |
| UK FTSE 100 | ISFU | -8.81% | -34.71% | -49.73% | -64.20% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -6.84% | -33.41% | -34.48% | -40.53% |
| Hongkong Hang Seng | HSI | -9.45% | -37.77% | -33.16% | -37.92% |
| Japan Nikkei 225 | EXX7 | -5.66% | -25.92% | -47.91% | -70.80% |
| India NIFTY 50 | INDA | -5.05% | -29.83% | -50.49% | -78.95% |
| Brasil Bovespa | EWZ | -9.80% | -30.15% | -38.05% | -73.40% |
TXG 10X Genomics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.20% | -28.98% | -54.29% | -92.65% |
| Consumer Discretionary | XLY | -7.70% | -29.03% | -43.51% | -74.81% |
| Consumer Staples | XLP | -7.79% | -33.62% | -46.10% | -55.80% |
| Energy | XLE | -6.95% | -26.05% | -47.65% | -73.51% |
| Financial | XLF | -8.27% | -29.59% | -57.05% | -83.46% |
| Health Care | XLV | -6.86% | -30.04% | -44.89% | -61.79% |
| Industrial | XLI | -8.37% | -29.64% | -56.93% | -80.97% |
| Materials | XLB | -7.62% | -28.24% | -52.02% | -70.06% |
| Real Estate | XLRE | -8.17% | -26.28% | -42.34% | -56.71% |
| Technology | XLK | -11.24% | -29.86% | -50.13% | -90.06% |
| Utilities | XLU | -9.88% | -37.66% | -50.77% | -59.07% |
| Aerospace & Defense | XAR | -9.08% | -32.92% | -52.44% | -79.23% |
| Biotech | XBI | -7.83% | -29.09% | -61.51% | -58.31% |
| Homebuilder | XHB | -8.95% | -27.67% | -70.67% | -102.77% |
| Retail | XRT | -8.85% | -28.70% | -55.55% | -74.56% |
Does 10X Genomics outperform its market, is TXG a Sector Leader?
No, over the last 12 months 10X Genomics (TXG) made -53.45%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.34%.
Over the last 3 months TXG made -47.68%, while XLV made -1.06%.
No, over the last 12 months 10X Genomics (TXG) made -53.45%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 8.34%.
Over the last 3 months TXG made -47.68%, while XLV made -1.06%.
| Period | TXG | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -30.52% | -0.48% | -0.29% |
| 3 Months | -47.68% | -1.06% | 4.11% |
| 12 Months | -53.45% | 8.34% | 27.12% |